CSBBANKNSECSB Bank LimitedMediumNeutral
Announced Tue, 6 May · 17:44 IST

CSB Bank Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call

Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDF

CSBBANK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

CSB Bank reported FY25 net profit of INR 594 crores (5% YoY) and Q4 net profit of INR 190 crores (26% YoY). Operating profit grew 17% for FY and 39% for Q4, with other income surging 66% for the year (now 21% of total income) driven by treasury gains, gold loan processing fees, wholesale banking, and PSLC benefits. Net advances grew 29% YoY, more than double the industry average of 12%, led by gold loans (35%), SME (33%), retail ex-gold (24%), and wholesale/corporate (44% standalone). Asset quality improved with GNPA at 1.57% and NNPA at 0.52%, PCR strengthened to 67% (without PWO), and the bank holds an INR 185 crore provisioning buffer. CRAR is strong at 22.46%. The bank is in the final phase of a major tech transformation (Oracle CBS, OBDX), with the scale-up phase starting from FY27 under its SBS 2030 vision targeting a 30-20-30-20 mix of retail-SME-wholesale-gold.

Likely market impact

Management guided FY26 NIM around 4% (between 3.75% and 4%), saying margins have hit the bottom, with credit cost below 30 bps, ROA of 1.5-1.8%, and ROE of 15-17%. Asset growth of 20-25% is expected, constrained mainly by deposit gathering ability. The Q4 NIM dip to 3.75% was attributed to one-off excess liquidity, higher hedging costs on foreign borrowings, and unsecured book provisioning. Cost-to-income is expected around 65% until FY27, then improving to 50% by FY30 once tech transformation unlocks scale. Short-term, the stock may face volatility due to Q4 margin compression and tech migration risks, but the multi-year roadmap offers visibility on earnings recovery from FY27.